— Know what they know.
Not Investment Advice
Also trades as: 2269.HK (HKSE) · $vol 123M · WXXWY (OTC) · $vol 1M

WXIBF OTC

WuXi Biologics (Cayman) Inc.
1W: -2.8% 1M: -9.1% 3M: -20.4% YTD: -0.9% 1Y: +39.3% 3Y: -54.6% 5Y: -73.4%
$4.18
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Alpha Radar Sell · Power 46 · $17.3B mcap · 3.74B float · 0.0000% daily turnover · Short 85% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$17.3B
52W Range2.85-5.606
Volume32,250
Avg Volume507
Beta0.58
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOZhisheng Chen
Employees12,575
SectorHealthcare
IndustryBiotechnology
IPO Date2018-01-30
No. 108, Meiliang Road
Wuxi 214092
CN
+86 510 8183 5000
About WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms